Optimum Publishing International announces Wilful Blindness, How a network of narcos, tycoons and CCP agents infiltrated the West
May 17, 2021 07:30 ET
|
Optimum Publishing International
TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- Global Book Launch May 20th 4:00 P.M. EDT via Teleconference www.opibooks.com/events-1 Featuring Ivy Li, Dr. Teng Biao, Dr. Charles Burton, Benedict...
FibroGen to Report First Quarter 2021 Financial Results
May 03, 2021 07:00 ET
|
FibroGen, Inc
SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its first quarter 2021 financial results on Monday, May 10 after the market close. FibroGen will also...
FibroGen to Present at Upcoming Investor Conferences
May 27, 2020 07:00 ET
|
FibroGen, Inc
SAN FRANCISCO, May 27, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following...
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
March 02, 2020 16:01 ET
|
FibroGen, Inc
Roxadustat NDA submission accepted with PDUFA date of December 20, 2020Pamrevlumab pivotal trials for treatment of idiopathic pulmonary fibrosis (IPF) and locally advanced unresectable pancreatic...
FibroGen To Report Third Quarter 2019 Financial Results on Monday, November 11, 2019
November 04, 2019 07:00 ET
|
FibroGen, Inc
SAN FRANCISCO, Nov. 04, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that financial results for the third quarter 2019 will be released after market on Monday, November...
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment of Anemia in Cancer Patients Receiving Chemotherapy
September 26, 2019 07:00 ET
|
FibroGen, Inc
SAN FRANCISCO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced first patient dosed in the company’s Phase 2 clinical study of roxadustat, a first-in-class...
CITIZENS INC. ALERT: Rosen Law Firm Reminds Investors of Important Deadline in Their First-Filed Class Action – CIA
April 20, 2017 12:21 ET
|
The Rosen Law Firm PA
NEW YORK, April 20, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Citizens, Inc. securities (NYSE:CIA) from March 11, 2015 through March 8, 2017,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Citizens, Inc. – CIA
April 06, 2017 13:24 ET
|
The Rosen Law Firm PA
NEW YORK, April 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Citizens, Inc. securities...
Statement from the Canadian Institute of Actuaries (CIA) on New Democratic Party pledge on Canada/Quebec pension plans
September 03, 2015 16:10 ET
|
Canadian Institute of Actuaries
OTTAWA, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Rob Stapleford, President of the Canadian Institute of Actuaries (CIA), said today, "The Institute acknowledges Mr. Mulcair's pledge to convene a first...
Judicial Watch Obtains CIA Transcript of Brennan "Underwear Bomb" Briefing
December 17, 2013 15:31 ET
|
Judicial Watch
WASHINGTON, DC--(Marketwired - Dec 17, 2013) - Judicial Watch today released the full transcript of a May 7, 2012, teleconference between then-White House top counterterror adviser John Brennan and...